Product & Industry News
Page 1 to 16 of 20 |     NEXT PAGE >
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit
Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics

Read More

Vernalis and PhoreMost announce drug discovery collaboration
Ligand subsidiary Vernalis and PhoreMost Limited announce drug discovery collaboration for novel oncology target.

Read More

Avacta Group plc hits clinical candidate selection milestone for Affimer PD-L1 inhibitor
Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, announces that it has selected the clinical development candidate for first-time-in-human clinical trials of the Affimer platform.

Read More

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round
Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment.

Read More

Phoenix Molecular Designs and WuXi STA Reach Drug Supply Milestone
Phoenix Molecular Designs and WuXi STA Reach Drug Supply Milestone to Support Phase I/Ib Study of PMD-026 for TNBC

Read More

ERS Genomics licenses CRISPR gene editing technology
ERS Genomics licenses CRISPR gene editing technology to Bioneer to further advance preclinical disease modelling.

Read More

Loop Genomics launches four new Microbiome kits
Loop Genomics launches four new Microbiome kits leveraging their ability to perform long-reads on Illumina sequencers.

Read More

Expedeon AG adds CaptSure DIY ELISA to immunoassay technology product range
Addressing a billion-dollar market with innovative technologies which remove bottlenecks in research and discovery.

Read More

TTP plc collaborates with Quotient Ltd to transform transfusion diagnostics and beyond
TTP enables development of MosaiQ™ diagnostic platform for transfusion typing and disease screening

Read More

Mologic achieves breakthrough in point-of-care diagnostics
Mologic achieves breakthrough in ultra-sensitive point-of-care diagnostics and develops new platform technology.

Read More

TC BioPharm initiates Phase I trial of allogeneic gamma delta T cell therapy
TC BioPharm initiates Phase I trial of allogeneic gamma delta T cell therapy in Acute Myeloid Leukemia patients

Read More

US Patent Office Grants Charpentier/Doudna Key CRISPR Patent
US patent number 10,266,850 was previously involved in an interference proceeding.

Read More

Surge of Indian biosimilars market forecast in 2019
CPhI data predicts India to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production

Read More

Taconic Biosciences Launches TruBIOME
Taconic Biosciences Launches TruBIOME to Create Animal Models with Custom Microbiome Profiles

Read More

My Personal Therapeutics Announces Funding & Secures Exclusive Mount Sinai License
My Personal Therapeutics Announces Funding and Secures Exclusive Mount Sinai School of Medicine Technology License to Revolutionize Personalized Cancer Treatment

Read More

Bio-Rad Introduces Isotype-Specific Secondary Antibodies
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies.

Read More

Product & Industry News
Page 1 to 16 of 20 |     NEXT PAGE >